KERYX Biopharmaceuticals

We rely on prominent scientists and physicians to advise us on our KinAce platform and the clinical development of KRX-101.

The KinAce Scientific Advisory Board

James Broach, Ph.D.
Professor of Molecular Biology at Princeton University

Moshe Oren, Ph.D.
Dean of Biology at the Weitzman Institute of Science (Rehovot, Israel)

Susan S. Taylor, Ph.D.
Professor of Chemistry and Biochemistry at the University of California, San Diego and Investigator at the Howard Hughes Medical Institute

David Lawrence, Ph.D.
Professor of Biochemistry at the Albert Einstein College of Medicine

Aaron Ciechanover, Ph.D.
Professor of Biochemistry at the Technion School of Medicine (Haifa, Israel)

The KRX-101 Scientific Advisory Board

Steven M. Haffner, M.D.
Professor of Internal Medicine in the Department of Medicinal/Clinical Epidemiology at the University of Texas Health Science Center

Job Harenberg, Ph.D.
Professor of Internal Medicine and Head of the Department of Haemostaseology at the University of Manheim, Germany

Lawrence Hunsicker, M.D.
Professor of Medicine, Department of Nephrology, University of Iowa College of Medicine

Michael Mauer, Ph.D.
Professor of Pediatrics, Co-Director, Pediatric Nephrology, University of Minnesota

Giuseppe Remuzzi, M.D., FRCP
Director, Mario Negri Institute for Pharmacological Research, Negri Bergamo Laboratories

Bernard Zinman, Ph.D.
Director, Leadership at the Sinai Center for Diabetes